Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
about
Postoperative tamoxifen for ductal carcinoma in situContralateral prophylactic mastectomy: current perspectivesRole of Hyperthermia in Breast Cancer Locoregional Recurrence: A ReviewThe Right Treatment for the Right Patient – Personalised Treatment of Breast CancerAccelerated partial breast irradiation with brachytherapy: patient selection and technique considerations.Current view on ductal carcinoma in situ and importance of the margin thresholds: A reviewSociety of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In SituIs the false-positive rate in mammography in North America too high?Intra-operative radiological margins assessment in conservative treatment for non-palpable DCIS: correlation to pathological examination and re-excision rate.Indocyanine green-loaded nanoparticles for image-guided tumor surgery.Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-upAdjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data BaseEffect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.Improving Therapeutic Ratios with the Oncotype DX® Ductal Carcinoma In Situ (DCIS) ScoreA comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancerSociety of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentA randomized phase II presurgical trial of transdermal 4-hydroxytamoxifen gel versus oral tamoxifen in women with ductal carcinoma in situ of the breast.Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situBenefit of tamoxifen in estrogen receptor positive DCIS of the breast.Towards optimal treatment of ductal carcinoma in situ.Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?Multiple bone metastases detected 10 years after mastectomy with silicone reconstruction for DCIS and contralateral augmentationDuctal carcinoma in situ of the breast: correlation between histopathological features and age of patientsDuctal carcinoma in situ: a brief review of treatment variation and impacts on patients and society.Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.The biplanar oncoplastic technique case series: a 2-year review.Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysisBreast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.Role of the radiotherapy boost on local control in ductal carcinoma in situGenetic predisposition to ductal carcinoma in situ of the breastPerioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancerThe effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.Ductal carcinoma in situ: what can we learn from clinical trials?The role of preoperative bilateral breast magnetic resonance imaging in patient selection for partial breast irradiation in ductal carcinoma in situ.Radiotherapy after conservative surgery in ductal carcinoma in situ of the breast: a review.Ductal carcinoma in situ: recent advances and future prospects.
P2860
Q24198028-7B0B5596-0AE3-4036-AE45-3B3F8F8DE891Q26744320-6C4AA87B-BF00-4AC1-BC29-CF8C9D958806Q26753882-BC63A3CE-5E32-4679-897D-A0B861D89367Q26800260-A6556318-588C-4981-AFAB-1C21C9B0CEE6Q26801260-7B7D1A73-C31E-4721-B1AE-7B06BD3F693FQ26853548-00A88C36-F416-4DDA-921A-864F431332EBQ28075837-F9ED9BE5-7AE9-4F77-AB51-632CE3114EECQ30250289-26483915-729D-4450-80BE-5B445105095EQ30540225-0B0D7BB4-5730-47DC-A413-3588CC943425Q30632044-620DE0F7-7794-4B27-925B-1A9D37673042Q30646728-573446E3-F740-4E73-9F5D-C7603C277C40Q30982140-245CA379-8764-4BA4-8880-71D1FEFD0F76Q33617264-9AFAD60C-D903-4620-83A8-3B1567666DF6Q33708159-B6788C69-9D09-4A01-8D36-1040327186C9Q33763855-C1295C86-6EAE-46A5-BA75-8A376F5E9B0EQ33816606-5E8429BA-EFF6-4D9D-AF2F-BB58C0606872Q33877411-D68E231A-B23B-488D-BD9A-BE8C1E73CD61Q33914381-59C5B11A-2E55-4879-8E53-C3821FA89C19Q33924710-2963186D-7D2B-4CBF-BCA6-FC60930589A1Q33972903-D5B51C10-F6A2-499D-B64B-D32A37EA210BQ34023603-999D9992-7130-4615-B65F-C2B142CF686BQ34038325-97E174A0-E9F6-4A35-8BD4-1DCDE2F9FFF9Q34286347-3BF5A9D6-0DEC-415C-B654-7116CA030209Q34659455-4CCCA87E-963B-40E6-81A8-67B15466978DQ35213089-64BAEF57-79B5-412B-81D3-C5BA2ED50DDBQ35596095-E2DF67F0-F4AE-4253-8A01-0DF903DB0242Q35707981-69D3E357-159A-49E6-A533-B5ABD32026A7Q35743243-FCCDB539-0964-479E-A500-6AF0D9FED0A6Q35812120-F8FB7C07-ADE8-4527-9400-DAA89BC331FDQ35816292-3F334A45-508F-4B7D-B573-CB6A47030595Q35837432-E11C4C3F-0C6F-4FBF-8393-F9DCA7AA8FD7Q35904098-833FF0C0-F144-4E30-86E2-BA6F3ACDB266Q35925620-7BEE2776-57E1-4267-82ED-4079359C761DQ35945018-D1BF2C7F-7EA4-4E1A-9D14-EBB9085FC1DBQ35945945-69283B18-3860-42B3-B1A3-100A47DA4157Q35949533-54304835-7181-4B05-9499-BD4955C7DDCEQ35977573-FD0BAE34-1BE7-4F43-8F0E-7B07B50F1448Q35986315-C0A1E0CA-EE5E-4BAA-9898-CC4972128BA9Q35986389-8B94E34D-CD16-41FE-A06D-303EFE4FC01BQ35996817-B591FE6E-1A30-4826-A6F8-E747F1F7AE52
P2860
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long-term outcomes of invasive ...... ized clinical trials for DCIS.
@ast
Long-term outcomes of invasive ...... ized clinical trials for DCIS.
@en
type
label
Long-term outcomes of invasive ...... ized clinical trials for DCIS.
@ast
Long-term outcomes of invasive ...... ized clinical trials for DCIS.
@en
prefLabel
Long-term outcomes of invasive ...... ized clinical trials for DCIS.
@ast
Long-term outcomes of invasive ...... ized clinical trials for DCIS.
@en
P2093
P2860
P356
P1476
Long-term outcomes of invasive ...... mized clinical trials for DCIS
@en
P2093
Bernard Fisher
Eleftherios P Mamounas
Irene L Wapnir
James J Dignam
Joseph P Costantino
Norman Wolmark
Richard G Margolese
Stephanie R Land
Thomas B Julian
P2860
P304
P356
10.1093/JNCI/DJR027
P407
P577
2011-03-11T00:00:00Z